Clinical Trial Update: Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating 100 mg flibanserin taken every evening versus placebo in premenopausal women with hypoactive sexual desire disorder. Results from the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• ADDYI (flibanserin)

Snippet

Sponsor: Sprout Pharmaceuticals, Inc | Conditions: Sexual Dysfunctions, Psychological | Phase 3 | Status: COMPLETED | Results posted: 2014-05-19